###begin article-title 0
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Interaction between O-GlcNAc Modification and Tyrosine Phosphorylation of Prohibitin: Implication for a Novel Binary Switch
###end article-title 0
###begin p 1
Conceived and designed the experiments: SRA SM. Performed the experiments: SRA SM SM. Analyzed the data: SRA SM. Wrote the paper: SM.
###end p 1
###begin p 2
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 319 320 316 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 352 353 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 386 387 383 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 568 569 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 805 806 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1106 1107 1103 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1262 1263 1259 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1302 1303 1299 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1503 1504 1500 1501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1717 1718 1714 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Prohibitin (PHB or PHB1) is an evolutionarily conserved, multifunctional protein which is present in various cellular compartments including the plasma membrane. However, mechanisms involved in various functions of PHB are not fully explored yet. Here we report for the first time that PHB interacts with O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase, OGT) and is O-GlcNAc modified; and also undergoes tyrosine phosphorylation in response to insulin. Tyrosine 114 (Tyr114) and tyrosine 259 (Tyr259) in PHB are in the close proximity of potential O-GlcNAc sites serine 121 (Ser121) and threonine 258 (Thr258) respectively. Substitution of Tyr114 and Tyr259 residues in PHB with phenylalanine by site-directed mutagenesis results in reduced tyrosine phosphorylation as well as reduced O-GlcNAc modification of PHB. Surprisingly, this also resulted in enhanced tyrosine phosphorylation and activity of OGT. This is attributed to the presence of similar tyrosine motifs in PHB and OGT. Substitution of Ser121 and Thr258 with alanine and isoleucine respectively resulted in attenuation of O-GlcNAc modification and increased tyrosine phosphorylation of PHB suggesting an association between these two dynamic modifications. Sequence analysis of O-GlcNAc modified proteins having known O-GlcNAc modification site(s) or known tyrosine phosphorylation site(s) revealed a strong potential association between these two posttranslational modifications in various proteins. We speculate that O-GlcNAc modification and tyrosine phosphorylation of PHB play an important role in tyrosine kinase signaling pathways including insulin, growth factors and immune receptors signaling. In addition, we propose that O-GlcNAc modification and tyrosine phosphorylation is a novel previously unidentified binary switch which may provide new mechanistic insights into cell signaling pathways and is open for direct experimental examination.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 0 1 0 1 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</underline>
###xml 3 4 3 4 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</underline>
###xml 5 6 5 6 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</underline>
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra1">[1]</xref>
###xml 534 537 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra1">[1]</xref>
###xml 538 541 538 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Kolonin1">[5]</xref>
###xml 679 682 679 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Bickel1">[6]</xref>
###xml 826 829 826 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mielenz1">[7]</xref>
###xml 831 834 831 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Ikonen1">[8]</xref>
###xml 1031 1034 1031 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Rajalingam1">[9]</xref>
###xml 1244 1248 1244 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Law1">[10]</xref>
###xml 1268 1272 1268 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Xi1">[11]</xref>
###xml 1297 1301 1297 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Ravetch1">[12]</xref>
###xml 1450 1454 1450 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-vanderGeer1">[13]</xref>
###xml 1456 1460 1456 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Songyang1">[14]</xref>
###xml 1580 1583 1580 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra1">[1]</xref>
Prohibitin (PHB, also known as PHB1) and its homologue PHB2 are evolutionarily conserved proteins and have been shown to be involved in cell cycle progression, cell differentiation, gene transcription and mitochondrial functions [1]. However, mechanisms involved in various functions of PHBs are poorly characterized. PHB has been reported to be present in the plasma membrane especially in the lipid rafts of B cells, Caco-2 cells (a model intestinal epithelial cell), adipocytes, and endothelial cells of adipose tissue vasculature [1]-[5]. Lipid rafts has been known to serve as platforms for receptor tyrosine kinase signaling including insulin and B cell receptor signaling [6]. This involves tyrosine phosphorylation of various signaling intermediates and tyrosine phosphorylation dependent protein-protein interactions [7], [8]. PHB has been shown to be required for Ras-induced Raf-MEK-ERK activation in epidermal growth factor receptor signaling pathway however mechanism involved in this process remains to be determined [9]. Central and C-terminus part of PHB contain tyrosine residues (Tyr114 and Tyr259) which exist within a motif similar to tyrosine known to be phosphorylated in the epidermal growth factor and insulin receptors [10], in beta integrins [11] and in B cell receptors [12]. Phosphorylation of tyrosine residues within these motifs are known to be recognized by phospho tyrosine binding (PTB) domain of signaling proteins [13], [14]. Tyr114 and Tyr259 residues in PHB are highly conserved across species suggesting a functional role for these residues [1].
###end p 4
###begin p 5
###xml 41 42 41 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 65 66 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 145 146 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 261 265 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Whelan1">[15]</xref>
###xml 266 270 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Yang1">[16]</xref>
###xml 286 287 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 395 396 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 412 416 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Zachara1">[17]</xref>
###xml 490 494 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Whelan1">[15]</xref>
###xml 616 617 607 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 673 677 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Wells1">[18]</xref>
###xml 678 682 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Copeland1">[20]</xref>
###xml 881 882 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 907 917 898 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 966 973 957 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 978 986 969 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 997 998 988 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1073 1074 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
In addition to tyrosine phosphorylation, O-GlcNAc (O-linked beta-N-acetylglucosamine) modification of tyrosine kinase signaling intermediates by O-GlacNAc transferase (OGT) has been shown to play a regulatory role in receptor tyrosine kinase signaling pathways [15]-[16]. OGT transfers N-acetylglucosamine from UDP-GlcNAc to a hydroxyl oxygen of serine or threonine in a beta confirmation (beta-O-glycosylation) [17]. OGT itself undergo tyrosine phosphorylation which enhances OGT activity [15]. In many proteins a yin-yang relationship (i.e. same serine/threonine residues are subjected to both phosphorylation and O-GlcNAc modification under different conditions) exists [18]-[20], therefore it is not surprising that they influence and regulate each other because both modifications occur at the same residue. It is not known whether tyrosine phosphorylation can also influence O-GlcNAc modification and vice versa. Here we report that PHB interact with OGT both in vivo and in vitro and is an O-GlcNAc modified protein. In addition, we provide data which suggests that O-GlcNAc modification and tyrosine phosphorylation in a protein interact with each other. Implication of this study extends beyond protein specific binary switch and offers new mechanistic insights into tyrosine kinase signaling pathways.
###end p 5
###begin title 6
Results
###end title 6
###begin title 7
PHB interacts with OGT and is an O-GlcNAc modified
###end title 7
###begin p 8
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Whelan1">[15]</xref>
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra2">[21]</xref>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1A</xref>
###xml 379 386 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 445 452 445 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1B</xref>
###xml 667 668 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 695 696 695 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 905 906 893 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1001 1002 989 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1024 1031 1012 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1C</xref>
###xml 1080 1081 1068 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1235 1236 1223 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1254 1261 1242 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1C</xref>
###xml 1264 1265 1252 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1380 1381 1368 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 1484 1491 1472 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1D</xref>
###xml 1575 1576 1563 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1626 1633 1614 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1D</xref>
###xml 1676 1677 1664 1665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1788 1789 1776 1777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1947 1948 1935 1936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Because PHB and OGT both interact with insulin receptor and undergo tyrosine phosphorylation [15], [21], we examined whether PHB could interact with OGT. In co-immunoprecipitation assays, we found that both PHB and OGT co-immunoprecipitated with each other in response to insulin (Fig. 1A). A very weak signal was observed in the absence of insulin. This is further confirmed by in situ co-localization of PHB and OGT using confocal microscopy (Fig. 1B). This prompted us to examine whether PHB is subjected to modification by OGT. Cell lysates prepared from three different cell lines were analyzed by SDS-PAGE and processed for immunoblotting using monoclonal anti-O-GlcNAc antibody. Multiple O-GlcNAc modified protein bands were observed around expected approximately30 kDa PHB band. To confirm whether one of them is PHB, membranes were stripped and reprobed with anti-PHB antibody. Indeed one of the O-GlcNAc modified band exactly coincided with PHB band in overlay suggesting that PHB undergoes O-GlcNAc modification (Fig. 1C). Recombinant His-PHB was also detected by anti-O-GlcNAc antibody. A similar result was found when PHB was immunoprecipitated and analyzed by gel-electrophoresis and immunoblotting using monoclonal anti-O-GlcNAc antibody (Fig. 1C). O-GlcNAc modification of PHB was further confirmed by metabolic labeling of PHB with tetraacetylated azide-modified N-acetylglucosamine (GlcNAz) in C2C12 and NIH-3T3 cell lines and subsequent tagging with biotin alkyne (Fig. 1D). In both cell lines used, PHB was found labeled with GlcNAz sugar suggesting that O-GlcNAc modification of PHB is not cell specific (Fig. 1D). In insulin treated cells a more intense O-GlcNAc modified PHB band was observed in comparison to untreated controls suggesting that insulin facilitates O-GlcNAc modification of PHB. A similar result was found with RINm5F cells (data not shown). These data together suggest that PHB interacts with OGT and is an O-GlcNAc modified protein.
###end p 8
###begin title 9
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
PHB interacts with OGT and is O-GlcNAc modified.
###end title 9
###begin p 10
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 585 586 585 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 712 713 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 829 830 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1469 1470 1431 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 400 406 <span type="species:ncbi:9986">rabbit</span>
###xml 428 433 <span type="species:ncbi:10090">mouse</span>
###xml 1404 1409 <span type="species:ncbi:9796">horse</span>
###xml 1410 1416 <span type="species:ncbi:3726">radish</span>
(A) showing co-immunoprecipitation of PHB and OGT with each other. PHB and OGT co-immunoprecipitated from RINm5F cells with (100 nM) or without insulin treatment and immunoprecipitates were analyzed by immunoblotting using respective antibodies (left panel). In (B), in situ colocalization of PHB (green) and OGT (red) is shown in RINm5F cells by confocal microscopy. Cells were first incubated with rabbit anti-PHB (1:100) and mouse anti-OGT (1:500) antibodies and subsequently detected by FITC- and TRITC-conjugated secondary antibodies respectively. In (C), left panel showing anti-O-GlcNAc and anti-PHB immunoblots showing endogenous (__black triangle right) and recombinant PHB (black triangle right) as an O-GlcNAc modified protein. In the right panel same is shown after immunoprecipitation with anti-PHB antibody. In (D) O-GlcNAc metabolic labeling of PHB by GlcNAz sugar is shown. Cells were grown in the presence of azido-sugar for 72 hrs and then treated with or without insulin (100 nM). Subsequently azido sugar labeled proteins were ligated with biotin alkene and PHB was immunoprecipitated using anti-PHB antibody. Immunoprepitates were analyzed by gel-electrophoresis and immunoblotting using streptavidin-HRP conjugate and anti-PHB antibody. Representative blots of three or more experiments are shown. (Pr - primary, Pro-A - protein-A; IP - immunoprecipitation, Stvn-HRP - streptavidin horse radish peroxidase; GlcNAz - tetraacetylated azide-modified N-acetylglucosamine).
###end p 10
###begin title 11
O-GlcNAc modification and tyrosine phosphorylation affects each other
###end title 11
###begin p 12
###xml 27 28 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 660 663 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">105</sup>
###xml 672 673 672 673 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</underline>
###xml 672 673 672 673 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Y</underline></bold>
###xml 679 680 679 680 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 679 680 679 680 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 682 685 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">123</sup>
###xml 710 713 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">250</sup>
###xml 721 723 721 723 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TY</underline>
###xml 721 723 721 723 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TY</underline></bold>
###xml 732 735 732 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">268</sup>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 880 888 880 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1120 1127 1120 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2A</xref>
###xml 1157 1158 1157 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1381 1382 1381 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1456 1457 1456 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1475 1482 1475 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2A</xref>
###xml 1519 1520 1519 1520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1624 1625 1624 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 218 223 <span type="species:ncbi:9606">Human</span>
Because PHB undergoes both O-GlcNAc modification and tyrosine phosphorylation, we asked the question whether these modifications occur in neighboring residues and affect each other. Analysis of PHB protein sequence by Human Protein Reference Database, NetPhos and Scansite servers identified Tyr114 and Tyr259 as potential sites of phosphorylation. Interestingly two (i.e. Ser121 and Thr258) out of three potential O-GlcNAc sites (i.e. Ser101, Ser121 and Thr258) predicted (discussed later) in PHB are either adjacent to or in the close proximity of tyrosine phosphorylation sites (Tyr114 and Tyr259). Therefore, we used two synthetic peptides (Pep I - Biotin-105RIFTSIGEDYDERVLPSIT123-NH2 and Pep II - Biotin-250QLSRSRNITYLPAGQSVLL268-NH2) biotinylated at the N-terminus and amidated at the C-terminus spanning tyrosine phosphorylation and O-GlcNAc modification sites in PHB. In in vitro kinase assays using catalytic domain of insulin receptor (Upstate Biotechnology, NY, USA) and ATP (Sigma, ON, Canada) and subsequent analysis with immunoblotting we found that both peptides were phosphorylated at tyrosine residue (Fig. 2A). To determine the potential O-GlcNAc modification of tyrosine neighboring residues, biotinylated synthetic peptides of PHB were incubated with immunoprecipitated OGT and UDP-GlcNAc and subsequently analyzed with gel-electrophoresis and immunoblotting. O-GlcNAc modification was detected by immunoblotting using monoclonal anti O-GlcNAc antibody (Fig. 2A) suggesting that they had undergone O-GlcNAc modification. Because both peptides contain multiple serine and/or threonine residues therefore O-GlcNAc modification of these peptides at sites other than Ser121 and Thr258 may not be ruled out.
###end p 12
###begin title 13
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Interaction between O-GlcNAc modification and tyrosine phosphorylation of PHB.
###end title 13
###begin p 14
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 57 58 57 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 244 254 244 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 548 555 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 740 750 740 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro O</italic>
###xml 857 865 857 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1112 1113 1112 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1449 1450 1449 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
In (A) showing in vitro phosphorylation (left panel) and O-GlcNAc modification of PHB peptides (right panel) using insulin receptor and immunoprecipitated OGT respectively. In (B) effect of tyrosine phosphorylation on O-GlcNAc modification and vice versa are shown. To determine the effect of tyrosine phosphorylation on O-GlcNAc modification, PHB control peptides and phosphate blocked Tyr114 and Tyr259 containing peptides were incubated with OGT and UDP-GlcNAc and subsequently analyzed by gel-electrophoresis and immunoblotting as described in Methods (right panel). To determine the effect of O-GlcNAc modification on tyrosine phosphorylation, biotinylated-PHB peptides were first immobilized on streptavidin-agarose and then used for in vitro O-GlcNAc assays using OGT and UDP-GlcNAc. After washing (3x) in reaction buffer same peptides were used for in vitro kinase assays using catalytic domain of insulin receptor and ATP. Finally, peptides were analyzed by gel-electrophoresis and immunoblotting using anti-phospho tyrosine (left panel). (C and D) Effect of PHB mutants on tyrosine phosphorylation and O-GlcNAc modification of PHB are shown. PHB and OGT were immunoprecipitated from insulin (100 nM for 20 mts) treated RINm5F cells after 72 hrs of co-transfection with OGT and PHB/PHB mutants (Y114F, S121A, T258I and Y259F). Immunoprecipitates were analyzed with gel-electrophoresis and immunoblotting using anti-phosphotyrosine and anti-O-GlacNAc monoclonal antibodies. Representative blots of three or more experiments are shown. (Pep I - peptide I - pep II, peptide II, IR - insulin receptor, P - with phosphate group attached to tyrosine, NP - without phosphate group, IP - immunoprecipitation, pY - phosphotyrosine).
###end p 14
###begin p 15
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 174 184 174 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro O</italic>
###xml 290 291 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 383 390 383 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2B</xref>
###xml 666 667 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 692 702 692 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Wells1">[18]</xref>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Slawson1">[19]</xref>
###xml 734 735 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 895 905 895 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro O</italic>
###xml 1052 1053 1052 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1093 1101 1093 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1259 1260 1259 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1333 1340 1333 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2B</xref>
###xml 1420 1421 1420 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1450 1451 1450 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
To determine whether tyrosine phosphorylation modulates O-GlcNAc modification we used biotinylated synthetic peptides with a phosphate group attached to Tyr114 and Tyr259 in in vitro O-GlcNAc assays. Presence of phosphate at tyrosine residues (Tyr114 and Tyr259) significantly enhanced the O-GlcNAc modification of both peptides in comparison to non-phosphorylated control peptides (Fig. 2B). Similar results were found when peptides were phosphorylated using catalytic domain of insulin receptor (data not shown). This is in contrast to yin-yang sites in which phosphorylation at serine or threonine residues has been shown to be associated with down regulation of O-GlcNAc modification and vice versa[18]-[19]. To determine whether O-GlcNAc modification affect tyrosine phosphorylation, biotinylated peptides (Pep I and Pep II) were immobilized on streptavidin-agarose beads and processed for in vitro O-GlcNAc assays using immunoprecipitated OGT and UDP-GlcNAc. After washing, immobilized control peptides (without any modification) and OGT induced O-GlcNAc modified peptides were used for in vitro kinase assays using catalytic domain of insulin receptor and ATP. Interestingly tyrosine phosphorylation of these peptides was attenuated in the presence of O-GlcNAc modification in comparison to non-glycosylated control peptides (Fig. 2B). Taken together, these results suggest that tyrosine phosphorylation enhances O-GlcNAc modification whereas O-GlcNAc modification attenuates tyrosine phosphorylation at least in these peptides.
###end p 15
###begin title 16
Loss of tyrosine phosphorylation in PHB enhances OGT activity
###end title 16
###begin p 17
###xml 50 51 50 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 126 137 126 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">an in vitro</italic>
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 658 665 658 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2C</xref>
###xml 814 815 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1044 1051 1044 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2D</xref>
###xml 1069 1070 1069 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1250 1251 1250 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1450 1457 1438 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g003">Fig. 3A</xref>
###xml 1505 1506 1493 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1738 1739 1726 1727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1769 1770 1757 1758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1909 1916 1897 1904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g003">Fig. 3B</xref>
###xml 2111 2112 2099 2100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 2155 2156 2143 2144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 2233 2234 2218 2219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 2351 2358 2336 2343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g004">Fig. 4A</xref>
###xml 2435 2436 2420 2421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 2909 2910 2894 2895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 2958 2963 2943 2948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oryza</italic>
###xml 3029 3030 3014 3015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 3059 3066 3044 3051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g004">Fig. 4A</xref>
###xml 3443 3449 3428 3434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g004">Fig. 4</xref>
###xml 3725 3729 3710 3714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Whelan1">[15]</xref>
###xml 4003 4010 3988 3995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g003">Fig. 3C</xref>
###xml 4044 4045 4029 4030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 4169 4179 4154 4164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro O</italic>
###xml 4483 4490 4468 4475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g003">Fig. 3C</xref>
###xml 4537 4538 4522 4523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 2841 2846 <span type="species:ncbi:9606">human</span>
To determine whether tyrosine phosphorylation and O-GlcNAc modification of PHB interact within cells in the same manner as in an in vitro assay; Tyr114, Ser121, Thr258 and Tyr259 were substituted with phenylalanine, alanine, isoleucine and phenylalanine respectively by site-directed mutagenesis. Cells were transfected with wild type and PHB mutant vectors. After insulin treatment, PHB was immunoprecipitated and subsequently analyzed with gel electrophoresis and immunoblotting. An attenuation of tyrosine phosphorylation and O-GlcNAc modification was observed in Tyr114Phe and Tyr259Phe PHB mutants in comparison to wild type PHB in response to insulin (Fig. 2C) suggesting that Tyr114 and Tyr259 in PHB undergo phosphorylation in response to insulin and phosphorylation at these tyrosine residues facilitates O-GlcNAc modification of PHB. While substitution of Ser121 and Thr258 in PHB with alanine and isoleucine respectively resulted in reduced O-GlcNAc modification and increased tyrosine phosphorylation of PHB in response to insulin (Fig. 2D) suggesting that O-GlcNAc modification attenuates tyrosine phosphorylation of PHB. No difference was observed in the absence of insulin (data not shown). Surprisingly a significant up regulation of O-GlcNAc modification of some proteins in the molecular weight range of approximately50-100 kDa was also observed in response to insulin in cells transfected with Tyr114Phe and Tyr259Phe PHB mutants (Fig. 3A). Next we sought to know whether OGT itself is O-GlcNAc modified in cells transfected with tyrosine PHB mutants. To determine this, OGT was immunoprecipitated from untreated and insulin treated cells transfected with PHB tyrosine mutants and analyzed by immunoblotting using anti-O-GlcNAc antibody. An enhanced O-GlcNAc modification of OGT was observed in cells transfected with PHB mutants in comparison to wild type PHB in response to insulin only (Fig. 3B). To gain further insight into the mechanism involved, PHB sequence was analyzed with pBLAST search for any potential homology with OGT family members. Interestingly two OGT family members (UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 13 (Accession no. XP_515839.1) and beta-1,4-N-acetyl-galactosaminyl transferase 2 (Accession no. XP_548187.2) were identified with significant homology with PHB (Fig. 4A). Although it was very tempting to jump to the conclusion that PHB may have O-GlcNAc activity, however in both proteins PHB homologous region was not in the catalytic domain of these two enzymes indicating that it is unlikely that PHB has OGT activity. We speculate that these homologous regions in PHB and OGT family members are targeted by or interact with similar set of proteins and may have regulatory functions. In addition, homologous tyrosine motifs were also found between human OGT and central part of PHB containing Tyr114 and neighboring O-GlcNAc site that is Ser121; as well as between Oryza OGT and C-terminus part of PHB containing Tyr259 and neighboring O-GlcNAc site that is Thr258 (Fig. 4A). Subsequently we narrowed down our search to limit it to phospho tyrosine motifs in PHB and OGT family members. Interestingly pBLAST search for phospho tyrosine motifs in PHB limited to similar motifs in OGT family members revealed that tyrosine motifs in PHB containing Tyr114 and Tyr259 are very similar to tyrosine motifs present in various members of OGT family members (Fig. 4) suggesting that they may be targeted by similar tyrosine kinases and upon phosphorylation may interact with similar proteins. Recently OGT has been reported to interact with insulin receptor and insulin receptor induced tyrosine phosphorylation of OGT enhances OGT activity [15]. Therefore, we examined the tyrosine phosphorylation levels of OGT in cells co-transfected with OGT and PHB vectors in response to insulin. An increase in tyrosine phosphorylation of OGT was found with no change in OGT protein levels in cells transfected with PHB mutants (Fig. 3C). To ascertain whether increased O-GlcNAc modification of some proteins in the case of PHB mutants (Ty114Phe and Tyr259Phe) is due to increased OGT activity, in vitro O-GlcNAc assays were performed using immunoprecipitated OGT from insulin treated cells co-transfected with OGT and wild type PHB or tyrosine (Tyr114 and Tyr259) mutant-PHB. An increase in OGT enzyme activity was found consistent with increased tyrosine phosphorylation of OGT in comparison with controls (Fig. 3C). These data together suggests that increased O-GlcNAc modification of some proteins in cells transfected with PHB mutants were due to increased activity of OGT, most probably as a result of increased tyrosine phosphorylation of OGT.
###end p 17
###begin title 18
Enhanced tyrosine phosphorylation of OGT and OGT activity in cells transfected with PHB mutants (Y114F and Y259F) in response to insulin.
###end title 18
###begin p 19
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 315 316 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 693 703 693 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro O</italic>
(A) Effect of PHB/PHB mutant constructs on O-GlcNAc modification of various proteins in response to insulin in RINm5F cells is shown. In (B), cells were transfected with various PHB vectors and subsequently treated with or without insulin. OGT was immunoprecipitated using anti-OGT antibody and analyzed using anti-O-GlcNAc and anti-OGT antibodies. (C) RINm5F cells were co-transfected with OGT and PHB constructs. After 48 hrs serum starved cells were treated with insulin (100 nM) for 20 minutes. OGT was immunoprecipiataed using anti-OGT antibody and divided into two halves. One half was used for immunoblotting using anti-phospho tyrosine antibody (left panel). Another half was used for in vitro O-GlcNAc assay using PHB synthetic peptide II as a substrate and UDP-GlcNAc. Modified substrate was analyzed by immunoblotting using anti-OGT antibody. Subsequently immunoblots were analyzed by densitometry using NIH image analysis software. Normalized OGT activity is shown in the lower panel. Representative blots of three or more experiments are shown. Experiments were repeated for three times. (IP - immunoprecipitation, pY - phosphotyrosine).
###end p 19
###begin title 20
PHB and OGT family members contain similar tyrosine motifs.
###end title 20
###begin p 21
###xml 330 331 330 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 529 530 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 754 755 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 798 799 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 855 856 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 222 227 <span type="species:ncbi:9606">human</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
Multiple sequence alignments of PHB with OGT family members, as well as tyrosine motifs of PHB containing Tyr114 and Tyr259 with various OGT family members having similar motifs are shown. (A) showing sequence homology of human PHB with GlcNAc13, 4GalNT2, human OGT and Oryza OGT. Potential sites of tyrosine phosphorylation (*), O-GlcNAc modification (o) and proline residues (black triangle down) at -1 and/or +3 position from potential O-GlcNAc sites are shown. Multiple serine/threonine residues in the vicinity of potential O-GlcNAc sites are shown in the box (square). (B) showing motif containing Tyr114, and (C) showing motif containing Tyr259 in PHB. Conserved residues are shown in red and identical residues are shown in blue. (GlcNAc13 - UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 13, 4GalNT2 - beta-1,4-N-acetyl-galactosaminyl transferase 2).
###end p 21
###begin title 22
O-GlcNAc modification and tyrosine phosphorylation - A novel binary switch
###end title 22
###begin p 23
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 121 131 121 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 303 312 303 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s001">Tables S1</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s002">S2</xref>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 529 537 529 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s001">Table S1</xref>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 888 889 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1003 1004 1003 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1218 1219 1218 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1364 1373 1364 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s001">Tables S1</xref>
###xml 1378 1380 1378 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s002">S2</xref>
###xml 1531 1539 1531 1539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s003">Table S3</xref>
To gain further insight into a potential global regulatory role of tyrosine phosphorylation on O-GlcNAc modification and vice versa, we analyze motifs around known sites of O-GlcNAc modified proteins, and known sites of phospho tyrosine containing proteins which are also known to be O-GlcNAc modified (Tables S1 and S2). Analysis of known O-GlcNAc modification sites in various proteins revealed that proline at -/+1 and/or -/+3 position from O-GlcNAc site(s) is the most favored residue for O-GlcNAc modification in a protein (Table S1). Therefore, to increase the possibility of finding clues for a potential interaction between O-GlcNAc modification and tyrosine phosphorylation within a protein, only those proteins were considered which met one of the following two sets of selection criteria: (i) having potential tyrosine phosphorylation site(s) in the close proximity of a known O-GlcNAc site(s) with proline residue(s) at -/+1 and/or -/+3 position of O-GlcNAc site(s) or (ii) having potential O-GlcNAc site(s) with proline residue(s) at -/+1 and/or -/+3 position in the close proximity of a known tyrosine phosphorylation site (in this category only those proteins were considered which are known to undergo O-GlcNAc modification however exact sites of modification are not known yet). A number of proteins were identified using each selection criteria (Tables S1 and S2) with strong association between these two modifications suggesting a potential interaction between these two dynamic modifications in many proteins (Table S3). Experiments are currently underway to further validate this hypothesis.
###end p 23
###begin title 24
Discussion
###end title 24
###begin p 25
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 108 114 108 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1</xref>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g001">Fig. 1D</xref>
We provide evidence that PHB interacts with OGT in response to insulin and undergoes O-GlcNAc modification (Fig. 1). O-GlcNAc modification of PHB was further confirmed by metabolic labeling with GlcNAz sugar (tetraacetylated azide-modified N-acetylglucosamine) in C2C12 and NIH-3T3 cell lines (Fig. 1D). The acetyl groups improve cell-permeability of the azido-sugars and are removed by non-specific carboxyl esterases before sugars are incorporated into biosynthetic pathway.
###end p 25
###begin p 26
###xml 24 25 24 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s001">Table S1</xref>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 287 294 287 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g004">Fig. 4A</xref>
###xml 408 409 408 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 424 427 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">258</sup>
###xml 427 429 427 429 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TY</bold>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">261</sup>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 531 534 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">101</sup>
###xml 534 535 534 535 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</bold>
###xml 538 541 538 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">104</sup>
###xml 555 558 555 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">120</sup>
###xml 559 560 559 560 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</bold>
###xml 563 566 563 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">124</sup>
###xml 569 576 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g004">Fig. 4A</xref>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 680 687 680 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2A</xref>
###xml 716 717 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 731 738 731 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 870 871 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 942 943 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1034 1038 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Ohn1">[22]</xref>
###xml 1051 1052 1051 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1418 1422 1418 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Rush1">[23]</xref>
###xml 1464 1465 1464 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1532 1533 1532 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Prediction of potential O-GlcNAc modification sites in PHB on the basis of known O-GlcNAc sites in several other proteins (Table S1) identified Ser101 (Proline at +3 position), Ser121 (Proline at -1 position) and Thr258 (Proline at +3 position) as potential O-GlcNAc modification sites (Fig. 4A). Interestingly, out of four tyrosine residues present in PHB, one of them (Tyr259) is adjacent to Thr258 within O-GlcNAc motif (258TYLP261) and second (Tyr114) is flanked by two other potential O-GlcNAc modification sites i.e. Ser101 (101SQLP104) and Ser121 (120PSITT124) (Fig. 4A). O-GlcNAc modification of biotinylated peptide spanning potential O-GlcNAc modification sites by OGT (Fig. 2A) suggested that it could be O-GlcNAc sites in vivo too. Subsequently this is confirmed by site-directed mutagenesis and immunoblotting. Recently PHB homologue PHB2 was identified as O-GlcNAc modified protein in stress granules and it has been shown that O-GlcNAc modification is required for aggregation of untranslated mRNA into stress granules [22]. Out of two O-GlcNAc modification sites we have identified in PHB, Ser121 is conserved in PHB2 and corresponding residue in PHB2 is Ser135. Interestingly neighboring tyrosine residue (Tyr114) in PHB is also conserved in PHB2 and corresponding residue in PHB2 is Tyr128. Tyr128 in PHB2 has been identified as phosphorylation site during phospho-tyrosine profiling in cancer cells [23]. It would be interesting to know whether O-GlcNAc modification in PHB2 occurs at Ser135. It is possible that O-GlcNAc modification and tyrosine phosphorylation in PHB2 interact in the same way as in PHB.
###end p 26
###begin p 27
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Han1">[24]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Cohen1">[25]</xref>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">254</sup>
###xml 398 399 398 399 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</underline>
###xml 399 402 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">258</sup>
###xml 512 513 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 623 624 623 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
In another study, PHB has been identified as a substrate for Akt however exact phosphorylation site remains to be determined [24]. Akt phosphorylates many proteins at serine/threonine residues that lie in Arg-Xaa-Arg-Xaa-Xaa-Ser/Thr motifs (where Xaa is any amino acid) and this motif is crucial for the specificity of Akt [25]. Analysis of PHB protein sequence reveals one potential motif 254RSRNIT258 (R-x-R-x-x-S/T) for Akt. Interestingly Tyr259 in PHB is present at tandem position from Akt motif and Thr258 O-GlcNAc site is part of Akt consensus motif (R-x-R-x-x-S/T). This would imply that Thr258 may be subjected to O-GlcNAc modification or phosphorylation under different conditions and phosphorylation status of adjacent tyrosine residue (Tyr259) may play a regulatory role in this process.
###end p 27
###begin p 28
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 643 649 643 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g005">Fig. 5</xref>
###xml 699 700 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 802 809 802 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2B</xref>
###xml 838 845 838 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 891 892 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 949 958 949 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2C&#8211;D</xref>
###xml 994 995 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1126 1132 1126 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004586-g002">Fig. 2</xref>
###xml 1609 1614 1609 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
Because PHB (as well as few other insulin signaling intermediates such as IRS, Akt, GLUT4 etc) undergoes both O-GlcNAc modification and tyrosine phosphorylation and these modification sites are either adjacent or in the close proximity to each other we hypothesize that O-GlcNAc modification and tyrosine phosphorylation may be a previously unidentified novel binary switch. This would imply that these modifications may interact and regulate each other under different conditions, provide read-out for different interacting partners, attribute multiple functions to the same protein and may play an important role in cell signaling cascades (Fig. 5). Using biotinylated peptides spanning potential O-GlcNAc modification and tyrosine phosphorylation sites we showed that they indeed affect each other (Fig. 2B). This is further confirmed in vivo by substituting tyrosine phosphorylation and O-GlcNAc modification sites by site-directed mutagenesis (Fig. 2C-D). In addition, an up regulation of O-GlcNAc modification of some proteins was observed in the absence of tyrosine phosphorylation sites in PHB in response to insulin (Fig. 2). Because PHB and OGT both interacts with insulin receptor, undergoes tyrosine phosphorylation and contain similar tyrosine motifs it is possible that they may be part of a protein complex which may also include kinases and phosphatases, and under such condition loss of a competitive tyrosine phosphorylation sites in PHB may affect tyrosine phosphorylation and activity of OGT. Indeed this is exactly what we found in our case and is consistent with recent report by Whelan et al (2008). However, both OGT and PHB contain similar phospho tyrosine motifs therefore recruitment and subsequent modulation by other phospho tyrosine binding (PTB) domain containing proteins cannot be ruled out and warrant further investigation.
###end p 28
###begin title 29
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
O-GlcNAc modification and tyrosine phosphorylation binary switch.
###end title 29
###begin p 30
###xml 26 27 26 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 347 348 347 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Schematic diagram showing O-GlcNAc modifications at serine/threonine residues and tyrosine phosphorylation at neighboring tyrosine residues can potentially regulate each other in a binary fashion and subsequently may regulate interaction with different partners or attribute multiple functions to proteins (O - serine/threonine, Y - tyrosine, G - O-GlcNAc, P - phosphorylation, TK - tyrosine kinase, Pase - phosphatase, OGT - O-GlcNAc transferase, ONase - O-GlcNAcase).
###end p 30
###begin p 31
###xml 169 170 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 187 197 187 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 199 207 199 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s001">Table S1</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s002">S2</xref>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 394 402 394 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004586.s003">Table S3</xref>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 859 860 859 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1193 1194 1193 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Using two stringent selection criteria (as discussed above) a number of proteins were identified with potential tyrosine phosphorylation sites in the proximity of known O-GlcNAc sites or vice versa (Table S1 and S2). In both cases, a strong association was found between presence of proline residues with O-GlcNAc site (59-93%), as well as O-GlcNAc and tyrosine phosphorylation sites (71-87%) (Table S3). Given the fact that our knowledge regarding O-GlcNAc sites in various proteins are very limited, this high degree of association between O-GlcNAc modification and tyrosine phosphorylation in various proteins suggests a functional link between these two dynamic modifications in the regulation of various cellular events. We speculate that presence of multiple proline residues around O-GlcNAc/phospho tyrosine cassette play an important role not only in O-GlcNAc modification but also in the recruitment of various interacting partners especially proteins/protein domains which are known to bind phosphorylated residues adjacent to proline residues. In addition, phosphorylation status of tyrosine may play a regulatory role in the cross-talk between serine/threonine phosphorylation and O-GlcNAc modification. This study offers a novel mechanistic insight in cell signaling pathways.
###end p 31
###begin title 32
Materials and Methods
###end title 32
###begin title 33
Cell culture, site directed mutagenesis and transfection
###end title 33
###begin p 34
###xml 574 612 568 606 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CAGCATCGGAGAGGACTTTGATGAGCGTGTGC 3&#8242;</named-content>
###xml 627 665 621 659 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; GCACACGCTCATCAAAGTCCTCTCCGATGCTG 3&#8242;</named-content>
###xml 683 717 677 711 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TCTCGGAACATCACCTTCCTGCCAGCGG 3&#8242;</named-content>
###xml 732 766 726 760 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCGCTGGCAGGAAGGTGATGTTCCGAGA 3&#8242;</named-content>
###xml 784 819 778 813 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; AGCGTGTGCTGCCGGCCATCACAACTGAG 3&#8242;</named-content>
###xml 834 869 828 863 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTCAGTTGTGATGGCCGGCAGCACACGCT 3&#8242;</named-content>
###xml 887 922 881 916 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CTCTCGGAACATCATCTACCTGCCAGCGG 3&#8242;</named-content>
###xml 937 972 931 966 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCGCTGGCAGGTAGATGATGTTCCGAGAG 3&#8242;</named-content>
###xml 1386 1390 1380 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra3">[26]</xref>
###xml 290 295 <span type="species:ncbi:9606">human</span>
For all cell based experiments cells were grown in 100 mm culture dish in RPMI-1640 (ATCC, USA) complete growth media containing 10% FBS, 1% antibiotic-antimycotic at 37degreesC. OGT construct was obtained from Prof. Gerald Hart, University of John Hopkins. The pCMV6-XL5 vector containing human PHB clone (Reference sequence XM_056688) was obtained from Origene technologies, USA. PHB mutants were made using site-directed mutagenesis kit (Stratagene, USA) following manufacturer's instructions. The following primers were used for generating PHB mutants: Y114F, Forward - 5' CAGCATCGGAGAGGACTTTGATGAGCGTGTGC 3' and reverse - 5' GCACACGCTCATCAAAGTCCTCTCCGATGCTG 3'; Y259F: Forward -5' TCTCGGAACATCACCTTCCTGCCAGCGG 3' and reverse - 5' CCGCTGGCAGGAAGGTGATGTTCCGAGA 3'; S121A Forward - 5' AGCGTGTGCTGCCGGCCATCACAACTGAG 3' and reverse - 5' CTCAGTTGTGATGGCCGGCAGCACACGCT 3'; T258I Forward - 5' CTCTCGGAACATCATCTACCTGCCAGCGG 3' and reverse - 5' CCGCTGGCAGGTAGATGATGTTCCGAGAG 3'. Authenticity of all constructs was confirmed by DNA sequencing at Cancer Care Manitoba. Transfections were performed using lipofectamine (Invitrogen, USA), according to manufacturer's protocol. After 48 hrs of transfection cells were serum starved and treated with insulin (100 nM) for 20 minutes. Cell lysates were prepared in lysis buffer (50 mM Tris-Cl, pH 7.4) containing protease and phosphatase inhibitors [26] and subsequently processed for immunoprecipitation using specific antibodies as described below.
###end p 34
###begin title 35
Recombinant protein and peptides
###end title 35
###begin p 36
###xml 56 72 56 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 175 182 175 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">105&#8211;123</sup>
###xml 191 198 191 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">250&#8211;268</sup>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 56 72 <span type="species:ncbi:562">Escherichia coli</span>
Recombinant human His-tagged PHB (His-PHB) expressed in Escherichia coli and purified by His-affinity column was obtained from AmProx Inc. (Carlsbad, CA, USA). Custom made PHB105-123 and PHB2250-268 peptides (Pep I and Pep II) were chemically synthesized as 19mer peptide amidated at C-terminus and biotinylated at N-terminus. The correct peptides were obtained in greater than 90% yield and were homogeneous after purification as confirmed by mass and analytical HPLC.
###end p 36
###begin title 37
Immunoprecipitation and Western blot
###end title 37
###begin p 38
###xml 750 754 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra3">[26]</xref>
###xml 229 235 <span type="species:ncbi:9986">rabbit</span>
Immunoprecipitation of PHB and OGT was performed using Dynabeads Protein A and DynaMag (Invitrogen, USA) according to manufacturer's protocol. In brief, to 1 ml of cell lysate (adjusted for equal amount of protein), 10 microl of rabbit polyclonal anti-PHB antibody or monoclonal OGT antibody were added and incubated overnight on a rotating device at 4degreesC. At the end of the incubation, 25 microl of Dynabeads protein A suspension were added to each tube and further incubated for 2 h. Subsequently, pellets were washed (5x) in ice cold PBS, resuspended and used for in vitro assays and Western blot. Immunoprecipitated proteins were separated on 12% SDS-PAGE and transferred to nitrocellulose membrane for Western blotting as described earlier [26].
###end p 38
###begin title 39
Confocal microscopy
###end title 39
###begin p 40
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 329 335 <span type="species:ncbi:9986">rabbit</span>
RINm5F cells were cultured in chambered slides, fixed with 4% formaldehyde in PBS and incubated with antibodies to OGT (Santa Cruz Biotechnology, USA), and PHB (Cell Signaling, USA) at a concentration of 1 microg/ml in PBS containing 0.1% BSA. Immune complexes were detected with TRITC and FITC conjugated antibodies to mice and rabbit (Sigma, Oakville, ON) respectively.
###end p 40
###begin title 41
O-GlcNAc metabolic labeling of PHB
###end title 41
###begin p 42
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 227 228 227 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 514 518 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra3">[26]</xref>
###xml 553 559 <span type="species:ncbi:9986">rabbit</span>
O-GlcNAc metabolic labeling was performed using Click-iT GlcNAz metabolic glycoprotein labeling reagent (tetraacetylated N-azidoacetylgalactosamine and glucosamine) from Invitrogen, USA. In brief, cultures were seeded at 2.5x105 cells/ml in 100 mm tissue culture dish and allowed to grow for 72 hrs in the presence of 40 microM tetraacetylated azido-sugar. Cell lysates were prepared with or without insulin treatment in lysis buffer (1% SDS, 50 mM Tris-HCl, pH 8.0) containing protease and phosphatase inhibitors [26]. PHB was immunoprecipitated using rabbit anti-PHB antibody (Cell Signaling, USA) and Dynabeads Protein A (Invitrogen, USA) and subsequently analyzed with Click-iT Protein Analysis Detection Kit (Invitrogen, USA) according to manufacturer's protocol.
###end p 42
###begin title 43
In vitro phosphorylation assay
###end title 43
###begin p 44
###xml 50 53 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">105</sup>
###xml 62 63 58 59 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y</underline>
###xml 62 63 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>Y</underline></bold>
###xml 69 70 65 66 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</underline>
###xml 69 70 65 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>S</underline></bold>
###xml 72 75 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">123</sup>
###xml 100 103 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">250</sup>
###xml 111 113 107 109 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TY</underline>
###xml 111 113 107 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>TY</underline></bold>
###xml 122 125 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">268</sup>
###xml 564 565 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 693 703 675 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro O</italic>
###xml 965 973 947 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1143 1147 1125 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Mishra4">[27]</xref>
PHB synthetic peptides (2 microg) (Pep I - Biotin-105RIFTSIGEDYDERVLPSIT123-NH2 and Pep II - Biotin-250QLSRSRNITYLPAGQSVLL268-NH2, amidated at C-terminus and biotinylated at N-terminus) were incubated with 20 ng of recombinant active insulin receptor in kinase buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl2, 50 microM ATP) for 20 min at 30degreesC. At the end of assays, 10 microl of loading buffer was added to each tube and analyzed on 16% SDS-PAGE, transferred to nitrocellulose membranes and processed for Western blot as described above. To study the effect of O-GlcNAc modification on tyrosine phosphorylation peptides were first immobilized on streptavidin-agarose and then processed for in vitro O-glycosylation assay using immunoprecipitated OGT and UDP-GlcNAc. At the end of incubation, tubes were transferred to the ice and subsequently washed (3x) to remove reaction mixture and finally resuspended in 50 mM Tris-Cl buffer pH 7.4 for subsequent use in an in vitro kinase assay using catalytic domain of insulin receptor and ATP. Subsequently peptides were analyzed by gel-electrophoresis and Western blotting as described previously [27].
###end p 44
###begin title 45
In vitro O-GlcNAc assays
###end title 45
###begin p 46
###xml 239 243 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004586-Whelan1">[15]</xref>
###xml 405 406 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 528 536 514 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
PHB peptides (Pep I and Pep II) containing Ser121 and Thr258 were incubated with immunoprecipitated OGT in assay buffer (0.50 mM Na-Cacylodate pH 6.5, UDP-GlcNAc, 0.250 mM NaF) in a total reaction volume of 40 microl for 2 h at 30degreesC [15]. Reaction was stopped by adding 10 microl of SDS-PAGE loading buffer and subsequently analyzed with gel-electrophoresis and immunoblotting using monoclonal anti-O-GlcNAc antibody. In some cases, biotinylated peptides were immobilized on streptavidin-agarose and subsequently used for in vitro assay as described above.
###end p 46
###begin title 47
Supporting Information
###end title 47
###begin p 48
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Protein sequences having potential tyrosine phosphorylation site in the vicinity of known O-GlcNAc site.
###end p 48
###begin p 49
(0.09 MB PDF)
###end p 49
###begin p 50
Click here for additional data file.
###end p 50
###begin p 51
###xml 35 36 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Protein sequences having potential O-GlcNAc site in the vicinity of known tyrosine phosphorylation known.
###end p 51
###begin p 52
(0.12 MB PDF)
###end p 52
###begin p 53
Click here for additional data file.
###end p 53
###begin p 54
###xml 21 22 21 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
Summary of potential O-GlcNAc and phospho tyrosine binary switch.
###end p 54
###begin p 55
(0.14 MB PDF)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
We thank Dr. Gregoire Nyomba for critical reading of the manuscript and Dr. Gerald W. Hart for generous gift of OGT construct.
###end p 57
###begin title 58
References
###end title 58
###begin article-title 59
The Prohibitins: Emerging roles in diverse functions.
###end article-title 59
###begin article-title 60
The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein.
###end article-title 60
###begin article-title 61
###xml 21 37 <span type="species:ncbi:90370">Salmonella typhi</span>
Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.
###end article-title 61
###begin article-title 62
Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines.
###end article-title 62
###begin article-title 63
Reversal of obesity by targeted ablation of adipose tissue.
###end article-title 63
###begin article-title 64
Lipid rafts and insulin signaling.
###end article-title 64
###begin article-title 65
Lipid rafts associate with intracellular B cell receptors and exhibit a B cell stage-specific protein composition1.
###end article-title 65
###begin article-title 66
Lipid microdomains and insulin resistance: is there a connection?
###end article-title 66
###begin article-title 67
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
###end article-title 67
###begin article-title 68
Outside-in integrin signal transduction aIIbb3-(GP IIb-IIIa) Tyrosine phoshphorylation induced by platelet aggragation.
###end article-title 68
###begin article-title 69
Tyrosine phosphorylation of the integrin beta 3 subunit regulates beta 3 cleavage by calpain.
###end article-title 69
###begin article-title 70
Immune inhibitory receptors.
###end article-title 70
###begin article-title 71
The PTB domain: a new protein module implicated in signal transduction.
###end article-title 71
###begin article-title 72
The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif.
###end article-title 72
###begin article-title 73
Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling.
###end article-title 73
###begin article-title 74
Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance.
###end article-title 74
###begin article-title 75
Cell signaling, the essential role of O-GlcNAc.
###end article-title 75
###begin article-title 76
Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc.
###end article-title 76
###begin article-title 77
A mitotic GlcNAcylation/ phosphorylation signaling complex alters the post-translational state of the cytoskeletal protein vimentin.
###end article-title 77
###begin article-title 78
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.
###end article-title 78
###begin article-title 79
Insulin induced phosphorylation of prohibitin at Tyr114 recruits Shp1.
###end article-title 79
###begin article-title 80
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly.
###end article-title 80
###begin article-title 81
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.
###end article-title 81
###begin article-title 82
Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells.
###end article-title 82
###begin article-title 83
The twentieth century struggle to decipher insulin signaling.
###end article-title 83
###begin article-title 84
Transglutaminase 2 kinase activity facilitates protein kinase A induced phosphorylation of retinoblastoma protein.
###end article-title 84
###begin article-title 85
Phosphorylation of histones by tissue transglutaminase.
###end article-title 85
###begin p 86
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 86
###begin p 87
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by funds from Manitoba Health Research Council (MHRC) and Winnipeg Health Sciences Centre Foundation to SM. SRA is a recipient of MHRC Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 87

